Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Vanni

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|March 19, 2020
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel DiseasesGian Paolo Caviglia, Chiara Rosso, Francesco Stalla, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver diseaseChiara Rosso, Lavinia Mezzabotta, Melania Gaggini, et al.
Disease Models & Mechanisms|July 18, 2015
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosisElena Turola, Salvatore Petta, Ester Vanni, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Cancer Medicine|July 6, 2017
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver diseaseBenedetta Donati, Alessandro Pietrelli, Piero Pingitore, et al.
Bone Marrow Transplantation|April 19, 2025
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trialFederico Ravaioli, Antonio Colecchia, Jacopo Peccatori, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of CholestasisVincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
JHEP Reports : Innovation in Hepatology|March 8, 2021
Real-world experience with obeticholic acid in patients with primary biliary cholangitisDaphne D'Amato, Antonio De Vincentis, Federica Malinverno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 6, 2022
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acidAntonio De Vincentis, Daphne D'Amato, Laura Cristoferi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 23, 2024
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary CholangitisAntonio De Vincentis, Javier Ampuero, Francesca Terracciani, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|March 19, 2020
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel DiseasesGian Paolo Caviglia, Chiara Rosso, Francesco Stalla, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver diseaseChiara Rosso, Lavinia Mezzabotta, Melania Gaggini, et al.
Disease Models & Mechanisms|July 18, 2015
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosisElena Turola, Salvatore Petta, Ester Vanni, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Cancer Medicine|July 6, 2017
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver diseaseBenedetta Donati, Alessandro Pietrelli, Piero Pingitore, et al.
Bone Marrow Transplantation|April 19, 2025
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trialFederico Ravaioli, Antonio Colecchia, Jacopo Peccatori, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of CholestasisVincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
JHEP Reports : Innovation in Hepatology|March 8, 2021
Real-world experience with obeticholic acid in patients with primary biliary cholangitisDaphne D'Amato, Antonio De Vincentis, Federica Malinverno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 6, 2022
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acidAntonio De Vincentis, Daphne D'Amato, Laura Cristoferi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 23, 2024
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary CholangitisAntonio De Vincentis, Javier Ampuero, Francesca Terracciani, et al.
Pageof 5